Home » Topics » Conferences

Conferences
RSS

Antiinflammatory and COX-2-inhibitory effects reported for rutaecarpine

Dec. 8, 1997

Zeneca selects EGFR-TK inhibitor for clinical evaluation

Dec. 8, 1997

IL-12 for treatment of malignant tumors

Dec. 8, 1997

Egis reports safe and effective new anxiolytic

Dec. 8, 1997

Therapeutic potential of PC-SOD evaluated preclinically

Dec. 5, 1997

OncoVax-P clinical data reported at scientific meeting

Dec. 5, 1997

New tacrine analogue designated for further development

Dec. 5, 1997

Preclinical results reported for JTE-522, a selective COX-2 inhibitor

Dec. 5, 1997

FR-173657 effective in models of kinin-dependent inflammation

Dec. 5, 1997

OR-1384 at least equieffective to 5-ASA in acute and chronic colitis in mice

Dec. 5, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...